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Background: Although Campylobacter jejuni is consistently ranked as one of the leading causes of bacterial
diarrhea worldwide, the mechanisms by which C. jejuni causes disease and how they are regulated have yet to be
clearly defined. The global regulator, CsrA, has been well characterized in several bacterial genera and is known to
regulate a number of independent pathways via a post transcriptional mechanism, but remains relatively
uncharacterized in the genus Campylobacter. Previously, we reported data illustrating the requirement for CsrA in
several virulence related phenotypes of C. jejuni strain 81–176, indicating that the Csr pathway is important for
Campylobacter pathogenesis.
Results: We compared the Escherichia coli and C. jejuni orthologs of CsrA and characterized the ability of the
C. jejuni CsrA protein to functionally complement an E. coli csrA mutant. Phylogenetic comparison of E. coli CsrA
to orthologs from several pathogenic bacteria demonstrated variability in C. jejuni CsrA relative to the known
RNA binding domains of E. coli CsrA and in several amino acids reported to be involved in E. coli CsrA-mediated
gene regulation. When expressed in an E. coli csrA mutant, C. jejuni CsrA succeeded in recovering defects in
motility, biofilm formation, and cellular morphology; however, it failed to return excess glycogen accumulation to
wild type levels.
Conclusions: These findings suggest that C. jejuni CsrA is capable of efficiently binding some E. coli CsrA binding
sites, but not others, and provide insight into the biochemistry of C. jejuni CsrA.
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Since its emergence as a pathogen of interest, Campylo-
bacter jejuni has consistently been listed as one of the
leading causes of infectious diarrhea throughout the devel-
oped world [1,2], and is the most common antecedent in-
fection associated with onset of the neurological disorder,
Guillain-Barré Syndrome [3]. Despite more than thirty
years of rigorous investigation, the exact mechanisms by
which C. jejuni causes disease in humans have eluded
researchers. Publications of the genome sequences of vari-
ous strains of C. jejuni revealed a surprising absence of* Correspondence: stthomps@georgiahealth.edu
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distribution, and reproduction in any mediummany genes encoding proteins required for signal trans-
duction and gene regulation. Although C. jejuni regulates
gene expression in response to oxidative stress, iron avail-
ability, pH, and growth temperature, it does so with only
three sigma factors, six sensor histidine kinases, and
eleven response regulators [4-11]. This limited repertoire
of regulatory elements and its overall lack of virulence fac-
tors has placed considerable importance on identifying
novel mechanisms of pathogenesis and gene regulation to
gain insight into the disease-causing mechanisms and cap-
abilities of the organism in an effort to prevent and treat
C. jejuni infections.
Observations reported by our laboratory and others
have suggested an important role for the post-
transcriptional regulator, CsrA (Carbon storage regulator),d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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types in C. jejuni [12-15]. In other bacteria, CsrA (or its
ortholog RsmA) is a small, regulatory protein capable of
both activating and repressing the translation of mRNA
into protein (reviewed by Romeo [16]). CsrA regulation is
mediated by binding mRNA, often at or near the ribo-
some binding site (RBS), resulting in altered translation
and stability of the message. CsrA, in turn, is regulated by
the action of competitively binding two small, non-coding
RNA molecules, csrB and csrC [16-20], whose expression
is activated by the BarA/UvrY two-component system
[19,21]. The CsrA pathway and the mechanism of regula-
tion have been studied extensively in the γ-proteobacteria
and further studies of the role of CsrA in various patho-
gens have extended its importance to the expression
of virulence factors and the regulation of pathogenesis
[22-26]. Despite these advances, very little is known about
the mechanism of action of CsrA in the ε-proteobacteria.
Examination of the C. jejuni genome [7,27-29] suggests
that this bacterium lacks several genes in the CsrA path-
way, including apparent orthologs of the small RNA mole-
cules csrB and csrC [30], the barA/uvrY two-component
signal transduction system, and csrD which is responsible
for csrB and csrC turnover [31]. One report describing the
role of CsrA in the gastric pathogen Helicobacter pylori
indicated that CsrA was required for motility, survival
under oxidative stress, and host colonization, and plays a
role in the expression of several virulence and oxidative
stress related proteins [23]. It was also suggested that the
H. pylori ortholog was unable to function when exogen-
ously expressed in E. coli because it failed to complement
the glycogen accumulation phenotype of an E. coli csrA
mutant [23].
Considering these observations in H. pylori, the phe-
notypes of a C. jejuni csrA mutant, and the lack of
knowledge concerning the functions of CsrA within the
ε-proteobacteria, we examined the ability of C. jejuni
CsrA to complement the phenotypes of an E. coli csrATable 1 Strains and plasmids used in this study
Strain or plasmid Description
Strains






pBAD-TOPO Cloning vector containing araBAD prom
pBADcsrAEC E. coli csrA cloned into pBAD-TOPO
pBADcsrACJ C. jejuni csrA cloned into pBAD-TOPO
#Tet, tetracycline; Kan, kanamycin; Strep, streptomycin; Amp, ampicillin.mutant with the hope of gaining further insight into the
molecular mechanism of C. jejuni CsrA. Phylogenetic
comparison revealed that C. jejuni CsrA exhibits vari-
ability in amino acids that constitute the published RNA
binding domains, as well as in other residues that are
important for CsrA-mediated regulation in E. coli. Sur-
prisingly, although the C. jejuni ortholog was unable to
complement the glycogen accumulation phenotype of
E. coli, successful rescue of several other E. coli mutant
phenotypes was achieved, demonstrating both similar-
ities and differences in the C. jejuni and E. coli Csr
systems.
Methods
Bacterial strains and routine growth conditions
All bacterial strains used in this study are listed in
Table 1. Overnight cultures of E. coli strains were rou-
tinely carried out at 37°C on LB agar or in LB broth with
shaking. One Shot® TOP10 chemically competent E. coli
(Invitrogen, Carlsbad, CA) was used as a cloning host
for TA-cloning procedures. E. coli MG1655 and
TRMG1655 (csrA::Kan) were obtained from T. Romeo
(University of Florida). When appropriate, E. coli strains
were selected in LB medium using ampicillin (100 μg/
ml) or kanamycin (50 μg/ml). Cloned genes were
induced by the addition of 0.002% L-arabinose to the
growth media. C. jejuni strain 81–176 was grown on
MH agar at 42°C under microaerophilic contitions (10%
CO2, 10% O2, and 80% N2) supplemented with 5%
sheep’s blood (Remel, Lenexa, KS).
Phylogenetic analyses
Phylogenetic comparison of CsrA orthologs was per-
formed by neighbor joining using CLUSTALW [34]
within the VectorNTI 7.1 program suite (Invitrogen,
Carlsbad, CA). Accession numbers for CsrA proteins
used in the comparisons are listed in Additional file 1:
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and the percent of bootstraps that supported the clusters
are indicated at each tree node (Figure 1A).
DNA and protein techniques
Genomic DNA from E. coli and C. jejuni strains for use
in PCR amplification was purified using the Generation
Capture Column Kit (Qiagen, Chatsworth, CA). The
plasmids used in this study were extracted and purified
using the QIAprep Spin Miniprep Kit (Qiagen). PCR
reactions were carried out using the Expand High Fidel-
ity PCR System (Roche, Mannheim, Germany). Primers
for PCR (Table 2) were synthesized by Integrated DNA
Technologies (Coralville, IA). All DNA sequencing was
performed by the GHSU Genomics Core Facility using
an ABI Prism 337 XL DNA sequencer (Applied Biosys-
tems, Foster City, CA). Western blots to validate the ex-
pression of CsrAEC and CsrACJ were performed by using
standard methods, with anti-his primary antibody


















E. coli    mliltrrvgetlmigdevtvtvlgvkgnqvri
S. typhim. mliltrrvgetlmigdevtvtvlgvkgnqvri




C. diff.   mlvisrkkdeavligdnievkvvgvdgnnikl
C. botul.  mlvitrkkgeslligddieitvvklddgsvkl
C. jejuni  mlilsrkenesiiigegieikvvqtgkgyakig



















Figure 1 C. jejuni CsrA is divergent from the E. coli ortholog, includin
pathogenic and non-pathogenic bacterial species were aligned using CLUS
of bootstrap replicates that support the adjacent branches. Protein lengths
Accession numbers for each protein are listed in Additional file 1: Table S1.
1 and 2 of E. coli CsrA important for RNA binding [35] are indicated by box
indicated by an asterisk (*). Red shading indicates amino acids that are iden
are different from E. coli CsrA but identical within the C. jejuni-containing c
of C. jejuni CsrA that are conservative substitutions compared to E. coli CsrAand goat, anti-mouse IgG-horseradish peroxidase sec-
ondary antibody (Pierce). All kits used in this study
were used according to the manufacturer’s provided
instructions.
Plasmid construction
Plasmids used in this study (Table 1) were constructed
using the pBAD-TOPO® TA Expression Kit (Invitrogen,
Carlsbad, CA) and initially cloned into One Shot®
TOP10 E. coli. The E. coli CsrA complementation plas-
mid, pBADcsrAEC, was constructed by amplifying the
endogenous E. coli csrA allele from MG1655 genomic
DNA using primers JAF401 and JAF402. The resulting
amplicon was then TA cloned into the pBAD-TOPO
vector such that CsrA expression was inducible by ara-
binose and detectable for western blot analysis by the
addition of a C-terminal hexahistidine tag. The C. jejuni
complementation vector, pBADcsrACJ, was constructed
by amplifying the C. jejuni csrA allele from 81–176 gen-












































g in the RNA binding domains. A) CsrA orthologs from 20 diverse
TALW (neighbor joining). Numbers at tree nodes indicate the percent
(number of amino acids) are indicated to the right of each ortholog.
B) Alignment of the amino acid sequences of CsrA orthologs. Regions
es and other amino acid residues important for CsrA regulation are
tical to those of E. coli CsrA; purple shading indicates amino acids that
lade of Figure 1A. Amino acids within RNA binding sequences 1 and 2
are underlined.
Table 2 Primers used in this study
Primer Sequence (50-30)
JAF 401 #GAG GAA TAA TAA ATG CTG ATT CTG ACT CGT CGA GTT GGT GAG
JAF 402 *TTA ATG ATG ATG ATG ATG ATG GTA ACT GGA CTG CTG GGA TTT
JAF 403 #GAG GAA TAA TAA TTA ATA TTA TCA AGA AAA GAA A
JAF 404 *TTA ATG ATG ATG ATG ATG ATG TTT GAT TAG TTT TTT GCT TA
#Underlined nucleotides indicate a manufacturer recommended addition to
remove vector encoded N-terminal leader sequence for expression of the native protein.
*Underlined nucleotides indicate a manufacturer recommended addition to
remove vector encoded C-terminal V5 epitope and add a polyhistidine tag for expression of the native protein.
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complementation vectors and empty pBAD-TOPO plas-
mid were then transformed into the E. coli csrA mutant
strain, TRMG1655, and recovered on LB agar containing
ampicillin and kanamycin. In all phenotypic testing, we
performed arabinose titration experiments (including
samples without added arabinose) to determine the
dose-responsiveness of CsrA expression and comple-
mentation ability.
Glycogen accumulation
Glycogen accumulation was assessed using previously
described methodologies [36]. Strains were grown at 37°C
on Kornberg agar (1.10% K2HPO4, 0.85% KH2PO4, 0.6%
yeast extract, 1.5% agar) with or without 2% (v:v) glycerol
or 2% (w/v) sodium pyruvate; either glycerol or pyruvate
was used as a carbon source as opposed to glucose due to
the inhibitory effect of glucose on the araBAD promoter
[37]. Briefly, cultures were spotted on agar in the pres-
ence or absence of a carbon source and grown overnight
at 37°C. Following incubation the cultures were stained
by exposure to iodine vapor by inverting the plates over
iodine crystals.
Motility
Motility was quantitated as previously described [38], in-
oculating semi-solid LB agar (0.35% agar) by stabbing
with an inoculating needle dipped into overnight cul-
tures and incubating for 14 hours at 30°C in a humidi-
fied incubator. After incubation, the diameter of the
zone of motility was measured. Experiments were per-
formed a minimum of three times with no fewer than
three replicates per experiment.
Biofilm formation
Quantitative biofilm formation was assessed as previ-
ously described [33]. Briefly, overnight cultures were
diluted 1:100 into LB broth. 100 μl aliquots were inocu-
lated into a 96-well, round bottomed polystyrene micro-
titer plate and incubated statically at 26°C for 48 hours.
Following incubation, biofilm accumulation was assessed
by the addition of 25 μl of 1% crystal violet (in 95%ethanol) and incubating at room temperature for 15
minutes, followed by rinsing the wells three times with
distilled H2O. Stained biofilms were quantitated by
measuring the OD570 after solubilization in 80% DMSO
for 24 hours at room temperature. Biofilm formation
was also assessed qualitatively by aliquoting 1 ml of
diluted culture into 5 ml polystyrene culture tubes and
incubating statically at 26°C for 24 hours. Biofilms were
then stained by the addition of 250 μl of crystal violet
and incubated for 15 minutes, washed three times with
distilled H2O, and photographed.
Electron microscopy
Cellular morphology was assessed by scanning electron
microscopy (SEM). Briefly, cultures were grown at 37°C
for 18 hours in the presence or absence of arabinose. The
cultures were then pelleted, and washed twice and resus-
pended in PBS (pH 7.2) and submitted to the GHSU
Electron Microsocopy Core Facility for SEM. Twelve
fields of view for each sample were randomly chosen for
analysis and imaged at 10000x magnification. The result-
ing micrographs where then analyzed to determine the
average length of the cells from each culture (n ≥ 150).
Cells that were obviously undergoing cell division or
those which were positioned on an inappropriate axis for
assessing length were excluded from analysis. The result-
ing data were then analyzed by one-way analysis of vari-
ables (ANOVA) to assess statistical significance among
the strains and to rule out variation within the twelve
fields of view for each strain as a source of error.
Statistical analysis
Results are presented as means ± standard error of
means. Statistical significance was determined using
ANOVA. P values of less than 0.05 were considered sta-
tistically significant.
Results
C. jejuni CsrA is evolutionarily divergent from E. coli
CsrA and exhibits diversity in amino acid residues im-











Figure 2 Glycogen accumulation in wild type, csrA mutant, and
complemented mutant strains of E. coli. Top Panel) MG1655
[pBAD], TRMG1655[pBAD], TRMG1655[pBADcsrAEC], and TRMG1655
[pBADcsrACJ] were spotted onto Kornberg agar supplemented with
2% glycerol and 0.002% L-arabinose and incubated at 37°C
overnight. The following day, the strains were stained for glycogen
accumulation by inverting over iodine crystals. Bottom Panel)
Expression of his-tagged CsrAEC and CsrACJ in TRMG1655 was
confirmed by western blot using anti-his primary antibodies.
Presence (+) or absence (−) of inducible CsrAEC or CsrACJ in each
strain is shown beneath the panels.
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genic and non-pathogenic bacteria (Figure 1A) showed
that CsrA proteins of the ε-proteobacteria C. jejuni and
H. pylori clustered distantly from most of the more thor-
oughly characterized enterobacterial orthologs. Further-
more, ε-proteobacterial CsrA proteins were of a larger
size (75–76 amino acids) compared to those most closely
related to E. coli (61–67 amino acids). The size differ-
ence was largely attributable to an C-terminal extension
in the larger CsrA proteins (Figure 1B). In contrast to
the high degree of amino acid conservation of CsrA
orthologs of E. coli, S. typhimurium, P. aeruginosa,
V. cholerae, and L. pneumophila, the CsrA proteins of
C. jejuni and H. pylori exhibited substantial divergence
from E. coli CsrA throughout (Figure 1B). This diversity
was also apparent in two domains that were shown to be
critical for RNA binding in E. coli CsrA [35]. In the most
N-terminal RNA binding region (amino acids 2–7),
C. jejuni CsrA shared four of six identical (two of six
similar) amino acids with E. coli CsrA (Figure 1B). The
C-terminal RNA binding region (amino acids 40–47)
showed greater diversity, with only two of eight identical
(three of eight similar) amino acids. Two additional
amino acids that were shown to be important for regula-
tion by E. coli CsrA (positions 19 and 35, marked by
asterisks in Figure 1B) also were not conserved in
C. jejuni CsrA. Together, these differences suggested the
possibility that C. jejuni CsrA may regulate protein ex-
pression by binding to somewhat different RNA
sequences than those bound by E. coli CsrA.
C. jejuni CsrA is unable to repress E. coli glycogen
biosynthesis
CsrA regulates E. coli glycogen biosynthesis via its effect
on the genes in the glgCAP operon [12], and an E. coli
csrA mutant accumulates significantly more glycogen
than wild-type cells (Figure 2). A previous report indi-
cated that the H. pylori ortholog of CsrA was unable to
complement the glycogen biosynthesis phenotype of the
E. coli csrA mutant [23]. Considering the close phylogen-
etic relationship between C. jejuni and H. pylori, we
sought to determine the complementation potential of
the Campylobacter ortholog for this phenotype. We
expressed CsrA proteins from C. jejuni and E. coli (con-
trol) in an E. coli csrA mutant under the control of the
arabinose-inducible araBAD promoter and examined
glycogen accumulation on Kornberg agar in the presence
of both glycerol (Figure 2) and pyruvate (data not
shown). Glycerol and pyruvate were used as carbon
sources to drive glycogen biosynthesis rather than glu-
cose due to the inhibitory affect of glucose on the
araBAD promoter [37]. In the presence of arabinose, we
found that expression of C. jejuni CsrA in the E. coli
mutant strain failed to repress gluconeogenesis, resultingin glycogen staining similar to that of the mutant strain
harboring the vector alone. Expression of E. coli CsrA
restored wild-type levels of glycogen staining, as
expected, and the presence of the vector alone had no
effect on glycogen accumulation in the wild-type strain.
Expression of both orthologs of CsrA was confirmed by
western blot analysis (Figure 2).
Expression of C. jejuni CsrA rescues the motility defect of
an E. coli csrA mutant
In E. coli, CsrA regulates motility by activating the regu-
latory operon flhDC [38], via stabilization of the flhDC
transcript when post-transcriptionally bound by CsrA
in vivo. In the absence of CsrA, E. coli cells exhibit a
four-fold decrease in FlhDC expression resulting in a
loss of motility. We compared the motility of wild-type
and csrA mutant E. coli containing the vector alone to
that of the csrA mutant strain expressing CsrA from
E. coli or C. jejuni (Figure 3). We found that the C. jejuni
ortholog significantly (p<0.0001) rescued the motility de-
fect in a manner similar to that of E. coli CsrA
(p<0.0001). Neither ortholog of CsrA successfully com-
plemented motility in the absence of arabinose (data not
shown) and the vector had no effect on motility in either
the wild-type or mutant compared to the parent strains
(data not shown). Western blots were used to confirm
CsrA expression (Figure 3).
C. jejuni CsrA complements the biofilm formation
phenotype of an E. coli csrA mutant
Biofilm formation is repressed by CsrA in E. coli, result-
ing in the formation of excess biofilm by the csrA mu-












Figure 3 CsrACJ complements the motility defect of the E. coli
csrA mutant. The motility of MG1655[pBAD], TRMG1655[pBAD],
TRMG1655[pBADcsrAEC], and TRMG1655[pBADcsrACJ] was assessed
on semisolid (0.35%) LB agar after 14 hours of growth at 30°C. Top
Panel) Representative motility zones are shown, along with a graph
of the measured zones of motility in three separate repetitions
(n = 20/ repetition). Bottom Panel) Expression of his-tagged CsrAEC
and CsrACJ in TRMG1655 was confirmed by western blot using
anti-his primary antibodies. Presence (+) or absence (−) of inducible
CsrAEC or CsrACJ in each strain is shown beneath the panels. ANOVA
was performed to determine statistical significance of TRMG1655













Figure 4 CsrACJ restores wild type E. coli biofilm formation.
Biofilm formation in MG1655[pBAD], TRMG1655[pBAD], TRMG1655
[pBADcsrAEC], and TRMG1655[pBADcsrACJ] were assessed in either
polystyrene culture tubes (top panel; both side and bottom view of
polystyrene culture tubes are represented.) or 96-well polystyrene
microtiter dishes (quantitated in graph) using crystal violet staining
after static growth for 48 hours at 26°C. Bottom Panel) Expression of
his-tagged CsrAEC and CsrACJ in TRMG1655 was confirmed by
western blot using anti-his primary antibodies. Presence (+) or
absence (−) of inducible CsrAEC or CsrACJ in each strain is shown
beneath the panels. ANOVA was performed to determine statistical
significance of TRMG1655 expressing recombinant CsrAEC or CsrACJ
versus TRMG1655[pBAD] (* p<0.001).
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cosamine (PGA)[15]. To determine the ability of C.jejuni
CsrA to regulate biofilm formation in E. coli, we grew
wild-type, mutant, and complemented strains statically,
in 96-well polystyrene microtiter plates or in polystyrene
culture tubes for 24 hours at 26°C and stained biofilms
with crystal violet as previously described (Figure 4). As
expected, the E. coli csrA mutant produced excess bio-
film when compared to the wild-type; biofilm formation
of neither the wild-type nor the mutant strains was
affected by the presence of the vector (data not shown).
As expected, E. coli CsrA complemented the mutant
biofilm phenotype. Similarly, C. jejuni CsrA expression
significantly reduced biofilm formation in the mutant to
levels similar to that of wild-type (p<0.001). CsrA ex-
pression was confirmed by western blots (Figure 4).
C. jejuni CsrA expression restores the E. coli csrA mutant to
wild-type morphology
We sought to examine reported morphological differ-
ences between the wild-type E. coli and csrA mutant
strains and determine the capability of C. jejuni CsrA to
complement the observed difference in cell size. We
grew wild-type and mutant strains containing the vector
alone and mutant strains containing the pBADcsrAECand pBADcsrACJ complementation vectors in the pres-
ence or absence of arabinose and measured the length of
the cells (Figure 5). When grown in the absence of ara-
binose, we observed the reported elongated phenotype
of the csrA mutant [36] which was unaffected by the
presence of the vector. Interestingly, in the presence of
arabinose, we observed a substantial increase in the
length of wild type cells (Figure 5A), which was not evi-
dent in the mutant (Figure 5B; p<0.001). Expression of
CsrA from both E. coli and C. jejuni (Figures 5C and 5D,
respectively) significantly returned the mutant to the
wild type dimensions (p<0.001). Western blot analysis
confirmed expression of CsrA in the complemented mu-
tant strains (data not shown).
Discussion
Presently, studies from C. jejuni and the closely related
gastric pathogen, H. pylori, report mostly the phenotypic
effects of csrA mutation [13,23]. Furthermore, in
C. jejuni as well as H. pylori the small RNA molecules
(e.g. csrB, csrC) and the other proteins (e.g. CsrD)
known to be involved in the Csr pathway in E. coli are
*
*
Figure 5 CsrACJ rescues the morphological phenotypes of the E. coli csrA mutant. (A) MG1655[pBAD], (B) TRMG1655[pBAD], (C) TRMG1655
[pBADcsrAEC], and (D) TRMG1655[pBADcsrACJ] were grown overnight at 37°C in LB media supplemented with 0.002% L-arabinose and imaged by
scanning electron microscopy. (E) Measured lengths of cells from SEM micrographs graphed for comparison. Presence (+) or absence (−) of
CsrAEC or CsrACJ in each strain is shown beneath the panels. ANOVA was performed to determine statistical significance of TRMG1655 expressing
recombinant CsrAEC or CsrACJ versus TRMG1655[pBAD] (* p<0.001).
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that the molecular mechanisms may be somewhat differ-
ent than those in E. coli. In this study, we sought to de-
termine the capability of the C. jejuni CsrA ortholog to
complement the phenotypes of an E. coli csrA mutant to
gain insight into the mechanisms of C. jejuni CsrA
function.
The E. coli csrA mutation has several phenotypes that
can be used as tools for determining the capability of
CsrA orthologs from other bacteria to complement the
well-characterized E. coli strain. For instance, mutation
of csrA in E. coli alters glycogen biosynthesis, biofilm ac-
cumulation, motility, and cellular morphology, as well as
several other cellular processes. Mercante and colleagues
[35] used the glycogen, biofilm, and motility phenotypes
as a means to analyze the effects of comprehensive
alanine-scanning mutagenesis of E. coli CsrA. In that
study, the authors were able to identify which amino
acids were most important for regulating glycogen bio-
synthesis, biofilm production, and motility, while also
defining two regions of CsrA that are responsible for
RNA binding.
When we compared representative CsrA orthologs
from other bacteria, we found that C. jejuni CsrA is con-
siderably divergent, as it clustered distantly from the
E. coli ortholog. In part this is due to the significantly
larger size of CsrA orthologs in the C. jejuni cluster
(75–76 amino acids) as compared to the E. coli cluster
(61–67 amino acids, Figure 1A). Considering the phylo-
genetic divergence of C. jejuni CsrA, we also examined
the amino acid sequences of several CsrA orthologs of
the pathogenic bacteria represented in Figure 1A to in-
vestigate the conservation of individual residues known
to be important for the function of E. coli CsrA [35],
and found that C. jejuni CsrA is considerably divergentin several key amino acid residues. Variability is found in
both RNA binding domains, region 1 and region 2, al-
though greater variation is found in region 2. The first
region, residues 2–8, contains only two conservative
substitutions (T5S and R7K) while the other four resi-
dues are identical. RNA binding region 2 is highly vari-
able consisting of two residues that are identical to
E. coli (R44 and E46), three similar amino acids (V40L,
V42I, and I47L), and three non-conservative substitu-
tions (S41M, H43L, and E45K). Between the defined
binding regions, there were two non-conservative substi-
tutions (T19E and N35E) we found to be particularly
interesting because of their reported ability to improve
the regulatory functions of CsrA in E. coli [35]. Pres-
ently, we are not able to draw any specific conclusions
as to the significance of the individual amino acid substi-
tutions in C. jejuni as compared to E. coli; however, it is
likely that this divergence from E. coli plays a role in the
ability of the C. jejuni ortholog to bind to E. coli targets
appropriately.
In several studies, researchers characterizing the CsrA
orthologues of different bacteria have used the glycogen
biosynthesis phenotype of the E. coli csrA mutant to de-
termine the functional similarities. One such study, of
particular interest to our laboratory, reported that the
H. pylori ortholog of CsrA would not functionally com-
plement the E. coli mutant as it failed to repress glyco-
gen biosynthesis [23]. It is likely that the H. pylori CsrA
complementation failure was due to differences in the
functional mechanism of ε-proteobacterial CsrA, how-
ever, this may have been specific to the two CsrA-
binding sites of the glgCAP mRNA but not to other
CsrA targets. To test this for C. jejuni CsrA, we exam-
ined the ability of CsrACJ to complement multiple E. coli
csrA mutant phenotypes. We first expressed the C. jejuni
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ity to repress glycogen biosynthesis under gluconeogenic
conditions. Similar to H. pylori CsrA, the C. jejuni CsrA
ortholog was incapable of repressing glycogen accumula-
tion in the E. coli csrA mutant.
We next examined the ability of the C. jejuni protein
to complement the motility, biofilm accumulation, and
cellular morphology phenotypes of the E. coli mutant as
well. As with glycogen biosynthesis, CsrA-mediated
regulation of biofilm formation in E. coli is based on re-
pression of a synthetic pathway, in this case the
pgaABCD operon [15]. However, CsrA mediated expres-
sion of PgaABCD appears to be more complicated than
that of glycogen biosynthesis, as it was reported that the
mRNA leader sequence of the operon contains as many
as six CsrA binding sites compared to the two binding
sites observed on the glg leader sequence. Regardless of
the complexity of the molecular mechanism of CsrA
regulation of PGA we found that, when expressed in the
E. coli csrA mutant, C. jejuni CsrA successfully comple-
mented the biofilm formation phenotype (p<0.001).
Considering that the regulation of the glg and pga
operons are both examples of CsrA-mediated repression
of a biosynthetic pathway, we wanted to determine the
ability of C. jejuni CsrA to substitute for its E. coli ortho-
log when the activation of gene expression is required.
Wei and colleagues demonstrated that CsrA is a potent
activator of flhDC expression and is therefore required
for synthesis of the E. coli flagellum [38]. When we
expressed C. jejuni CsrA within the non-motile E. coli
csrA mutant the phenotype was completely rescued
(p<0.001) suggesting that the C. jejuni ortholog is cap-
able of promoting FlhDC expression.
Finally, we assessed the ability of C. jejuni CsrA to res-
cue an uncharacterized phenotype such as the altered
cellular morphology of the E. coli csrA mutant. When
CsrA was discovered, Romeo and colleagues reported
that the csrA mutant displayed a greater cellular size as
compared to the wild type, which was most obvious in
early stationary phase [40]. This phenotype was
explained as a possible indirect effect of endogenous
glycogen accumulation. When we grew the wild type,
csrA mutant, and complemented E. coli strains in LB
media and observed their morphology via scanning elec-
tron microscopy, we observed a modest but significant
decrease in the size of the mutant as compared to the
wild-type as reported by Romeo [36] in the absence of
arabinose; however, in the presence of arabinose we
observed a marked decrease in the size of the mutant as
compared to the wild type (p<0.001). This decrease in
size was complemented by both orthologs of CsrA
(p<0.001). As Romeo suggested that the size differences
between the mutant and wild type may be due to the
role of endogenous glycogen cellular morphology, it ispossible that the presence of arabinose used for protein
expression may play a separate metabolic role within the
cell leading to the observed phenotype.
A number of studies have shown that regulation of
mRNA targets by E. coli CsrA is complex [12,15,35,41].
Mercante et al. [41] showed that proper regulation
depends on simultaneous binding of E. coli CsrA to mul-
tiple sites on target mRNAs, involving both of the RNA-
binding surfaces of CsrA, using a multi-site bridging
mechanism, and also the formation of higher order ribo-
nucleoprotein complexes. Therefore, it is possible that
the lack of regulation of the E. coli glg genes by C. jejuni
CsrA is not due just to simple binding of one glg site vs.
another, but rather due to changes in the dynamics (i.e.
not ‘all or nothing’) of one or more of these bridging or
ribonucleoprotein formation processes. For example,
even moderately decreased affinity of C. jejuni CsrA for
one of the glg sites may inhibit the formation of multi-
site bridges and ribonucleoprotein complexes and there-
fore not result in productive regulation.
Finally, the binding of some but not all E. coli CsrA
binding sites by C. jejuni CsrA infers that ε-
proteobacterial CsrA binding sites are likely to show at
least subtle differences from such sites in E. coli. It
further underscores that predictive algorithms based
solely or primarily on E. coli CsrA binding sites may
be problematic for identifying CsrA binding sites in ε-
proteobacteria and other divergent bacteria (Figure 1)
[30], and that experimental approaches are preferable
(such studies are ongoing in our lab).
Conclusions
This study has shown that CsrA from the ε-proteobacteria
C. jejuni exhibits substantial sequence divergence com-
pared to previously studied CsrA regulators from other
bacteria, including in the RNA-binding domains. The
ability of C. jejuni CsrA to complement some, but not
all, phenotypes of an E. coli csrA mutant demonstrates
both conservation and divergence of function, and sug-
gests that the C. jejuni ortholog may have differences
in binding specificity relative to its E. coli counterpart.
Studies to define the C. jejuni CsrA RNA binding site
are ongoing.
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